Eosinophilia associated with bupropion
- 162 Downloads
A 48-year-old woman started treatment with bupropion 150 mg once daily for depressive symptoms. After 19 days she presented to her family physician complaining of myalgia and non-productive cough. The physical examination was normal and laboratory investigations showed an eosinophil count of 4.7 × 109/L (0–0.5). The results of a basal test before to bupropion intake were within normal range including eosinophils (0.2 × 109/L). After ruling out other causes of eosinophilia, the physician decided to gradually discontinue bupropion, and a marked decrease in absolute eosinophil count was subsequently observed.
To the best of our knowledge, this is the third published case of bupropion-related eosinophilia. Although, in light of the case presented, the prevalence of this adverse effect seems to be low, an awareness that bupropion can be a potential cause of eosinophilia may lead to the avoidance of unnecessary diagnostic tests or referral to other specialists.
KeywordsAntidepressants Bupropion Depression Eosinophilia
Conflicts of interest
- 1.Product Information: WELLBUTRIN® (bupropion). Research Triangle Park, NC: GlaxoSmithKline. http://www.pdr.net/drugpages/productlabeling.aspx?mpcode=32704625 (2011). Accessed 19 Dec 2012.
- 2.Bupropion. DRUGDEX System. Greenwood Village, CO: Thomson Micromedex. Accessed 19 Dec 2012.Google Scholar
- 5.Weller PF. Approach to the patient with eosinophilia. In: Mahoney DH, Bochner BS, editors. UpToDate. UpToDate: Waltham, MA; 2012.Google Scholar
- 6.Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol. 2009. doi: 10.1155/2009/495863.
- 8.Australian Database of Adverse Event Notifications. www.tga.gov.au/daen/daen-entry.aspx. Accessed 19 Dec 2012.